rs17886760

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000359597.8(TP53):​c.994-1416A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0798 in 152,058 control chromosomes in the GnomAD database, including 811 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.080 ( 811 hom., cov: 32)

Consequence

TP53
ENST00000359597.8 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0570

Publications

6 publications found
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
TP53 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Li-Fraumeni syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
  • Li-Fraumeni syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • adrenocortical carcinoma, hereditary
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • bone marrow failure syndrome 5
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • colorectal cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • choroid plexus carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.256 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000359597.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
ENST00000359597.8
TSL:1
c.994-1416A>G
intron
N/AENSP00000352610.4
TP53
ENST00000413465.6
TSL:1
c.783-5646A>G
intron
N/AENSP00000410739.2
TP53
ENST00000714356.1
c.984-1416A>G
intron
N/AENSP00000519623.1

Frequencies

GnomAD3 genomes
AF:
0.0797
AC:
12106
AN:
151940
Hom.:
810
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.136
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.0483
Gnomad ASJ
AF:
0.0289
Gnomad EAS
AF:
0.268
Gnomad SAS
AF:
0.194
Gnomad FIN
AF:
0.0151
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0435
Gnomad OTH
AF:
0.0758
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0798
AC:
12130
AN:
152058
Hom.:
811
Cov.:
32
AF XY:
0.0804
AC XY:
5978
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.137
AC:
5679
AN:
41482
American (AMR)
AF:
0.0483
AC:
737
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0289
AC:
100
AN:
3466
East Asian (EAS)
AF:
0.268
AC:
1373
AN:
5124
South Asian (SAS)
AF:
0.192
AC:
925
AN:
4820
European-Finnish (FIN)
AF:
0.0151
AC:
160
AN:
10606
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0435
AC:
2958
AN:
67978
Other (OTH)
AF:
0.0779
AC:
164
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
538
1077
1615
2154
2692
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0520
Hom.:
167
Bravo
AF:
0.0841
Asia WGS
AF:
0.220
AC:
764
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
5.5
DANN
Benign
0.85
PhyloP100
-0.057
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17886760; hg19: chr17-7570978; API